Partner Content Partner Content 3 things you should know about ADaM standards Digging deeper into the Analysis Data Model (ADaM)
Partner Content Partner Content Using SDTM, ADaM, and SEND for Regulatory Submissions Using SDTM, ADaM, and SEND for Regulatory Submissions
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
